Skip to content

Therapy areas
Our drug candidate
Investors
Media
About Isofol

Search for:

English
Svenska

Therapy areas
Our drug candidate
Investors
Media
About Isofol

Search for:

English
Svenska

Interim report July-September 2026

By Jenny Brinkeby / March 18, 2026

Interim report April-June 2026

AACR 2026

Contact

Isofol Medical AB (publ)
Biotech Center
Arvid Wallgrens Backe 20
413 46 Gothenburg, Sweden

Telephone
+46 (0)31 13 73 31

E-mail
info@isofolmedical.com

Terms & policys

Policys

Isofols integritetspolicy (allmän)

Isofols Expanded Access Policy

Isofols Cookie Policy

Terms of use
This website is only intended for investors residing in Sweden.

Follow us

Newsletter
Get news, press releases & other information via e-mail.

Subscribe to our news

LinkedIn
Follow us on LinkedIn

Copyright © 2026 Isofol Medical

Meny

English
Svenska

Sök efter:

Therapy areas
Our drug candidate
Investors
Media
About Isofol

Isofol Investor & Scientific Update 2026

Isofol invites investors, shareholders, and other stakeholders to an Investor & Scientific Update in Stockholm on November 12 and Gothenburg November 13.

Agenda and registration >>

Scroll to Top